COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,845 Articles (22,553 medRxiv, 8,292 bioRxiv)

Most recent first Previous |  Page 1450: Articles 14491-14500  | Next

Effectiveness of the Covid-19 vaccine in preventing infection in dental practitioners: results of a cross-sectional questionnaire based survey
Kumar, S., Saxena, S., Atri, M., Chamola, S. K.
10.1101/2021.05.28.21257967 — Posted: 2021-05-30
Modeling the impact of COVID-19 vaccination in Lebanon: A call to speed-up vaccine roll out
Mumtaz, G. R., El-Jardali, F., Jabbour, M., Harb, A., Abu-Raddad, L. J., Makhoul, M.
10.1101/2021.05.27.21257937 — Posted: 2021-05-30
CoMix: Changes in social contacts as measured by the contact survey during the 1 COVID-19 pandemic in England between March 2020 and March 2021
Gimma, A., Munday, J. D., Wong, K. L., Coletti, P., van Zandvoort, K., Prem, K., CMMID COVID 1-9 Working Group, , Klepac, P., Rubin, G. J., Funk, S., Edmunds, W. J., Jarvis, C. I.
10.1101/2021.05.28.21257973 — Posted: 2021-05-30
Estimates of cases and hospitalizations averted by COVID-19 case investigation and contact tracing in 14 health jurisdictions in the United States
Jeon, S., Rainisch, G., Lash, R., Moonan, P. K., Oeltmann, J. E., Greening, B., Adhikari, B. B., Meltzer, M. I.
10.1101/2021.05.27.21257931 — Posted: 2021-05-30
Small Airways Disease is a Post-Acute Sequelae of SARS-CoV-2 Infection
Cho, J. L., Villacreses, R., Nagpal, P., Guo, J., Pezzulo, A. A., Thurman, A. L., Hamzeh, N. Y., Blount, R. J., Fortis, S., Hoffman, E. A., Zabner, J., Comellas, A. P.
10.1101/2021.05.27.21257944 — Posted: 2021-05-30
Injustices in pandemic vulnerability: A spatial-statistical analysis of the CDC Social Vulnerability Index and COVID-19 outcomes in the U.S.
Song, J., Wiebe, D., Solomon, S., South, E.
10.1101/2021.05.27.21257889 — Posted: 2021-05-30
Inference of SARS-CoV-2 generation times using UK household data
Hart, W. S., Abbott, S., Endo, A., Hellewell, J., Miller, E., Andrews, N., Maini, P. K., Thompson, R. N.
10.1101/2021.05.27.21257936 — Posted: 2021-05-30
Time scale performance of rapid antigen testing for SARS-COV-2: evaluation of ten rapid antigen assays
Abusrewil, Z., Alhudiri, I. M., Kaal, H., Edin El Meshri, S., Ebrahim, F. O., Dalyoum, T., Efrefer, A. A., Ibrahim, K., Ben Elfghi, M., Abusrewil, S., Elzagheid, A.
10.1101/2021.05.27.21257868 — Posted: 2021-05-30
Immune transcriptomes from hospitalized patients infected with the SARS-CoV-2 variants B.1.1.7 and B.1.1.7 carrying the E484K escape mutation
Lee, H. K., Knabl, L., Knabl, L., Wieser, M., Mur, A., Zabernigg, A., Schumacher, J., Kaiser, N., Furth, P. A., Hennighausen, L.
10.1101/2021.05.27.21257952 — Posted: 2021-05-30
A suitable murine model for studying respiratory coronavirus infection and therapeutic countermeasures in BSL-2 laboratories
Andrade, A. C. d. S. P., Campolina-Silva, G. H., Queiroz-Junior, C. M., de Oliveira, L. C., Lacerda, L. d. S. B., Pimenta, J. C., de Souza, F. R. O., Chaves, I. d. M., Passos, I. B., Teixeira, D. C., Bittencourt-Silva, P. G., Valadao, P. A. C., Rossi-Oliveira, L., Antunes, M. M., Figueiredo, A. F. A., Wnuk, N. T., Temerozo, J. R., Ferreira, A. C., Cramer, A., Oliveira, C. A., Duraes-Carvalho, R., Arns, C. W., Guimaraes, P. P. G., Costa, G. M. J., Menezes, G. B. d., Guatimosim, C., Silva, G. S. F. d., Souza, T. M. L., Barrioni, B. R., Pereira, M. d. M., Sousa, L. P. d., Teixeira, M. M., Costa, V. V.
10.1101/2021.05.28.446200 — Posted: 2021-05-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).